Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$13.05 +0.94%

+$0.15 today

Market cap
$331.67M
Beta
0.48
P/E (TTM)
9.3
EPS (TTM)
$1.22
52W Low $11.98High $20.56

Volume 0.04M

Average 0.03M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$30.25M

FY 2025 · Annual

+54.7% YoY

Investing Cash Flow

-$72,242.00

FY 2025 · Annual

Financing Cash Flow

-$41.18M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income7.76M26.64M20.38M11.55M27.33M
Depreciation & Amortization701K989K1.23M4.02M7.23M
Deferred Income Tax(114K)(14.31M)(2.74M)(8.64M)(10.36M)
Stock-Based Compensation139K403K1.19M1.07M1.74M
Change in Working Capital4.68M(3.03M)(3.28M)8.95M5.32M
Accounts Receivables2.56M(144K)1.71M(8.77M)2.7M
Inventory(758K)(502K)(830K)3.6M(2.44M)
Accounts Payables(1.23M)(1.45M)532K1.28M527.07K
Other Working Capital4.11M(940K)(4.69M)12.85M4.53M
Other Non-Cash Items652K(109K)(788K)2.6M(1.01M)
Operating Cash Flow13.81M10.58M16M19.55M30.25M
Capital Expenditures0(81K)(144K)(44K)(28.49K)
Acquisitions (Net)0000132.28K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00(123K)(80M)0
Investing Cash Flow0(81K)(144K)(80.04M)(72.24K)
Debt Repayment(828K)(56K)(111K)39.79M(35.61M)
Common Stock Issued0000218.76K
Common Stock Repurchased(1.72M)(1.99M)(5.56M)(176K)(5.48M)
Dividends Paid00000
Other Financing Activities75K132K426K(317K)(311.36K)
Financing Cash Flow(2.47M)(1.91M)(5.24M)39.3M(41.18M)
Effect of Forex Changes62K(292K)378K(786K)(194.92K)
Net Change in Cash11.41M8.29M10.99M(21.99M)(11.2M)
Free Cash Flow13.81M10.49M15.98M19.5M30.22M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$27.3M
+ D&A$7.2M
+ Stock-Based Comp$1.7M
- Deferred Tax-$10.4M
+ Working Capital$5.3M
- Other Non-Cash-$1.0M
= Operating Cash Flow$30.2M
- Capex-$28.5K
= Free Cash Flow$30.2M

Analysis

FY2025 free cash flow is $30.2M. FCF conversion is 110.6% of net income. Operating cash flow was $30.2M, with capex of -$28.5K. The largest bridge item is Deferred Tax at -$10.4M.

Recent Filings

Recent regulatory filings

No filings found.

Does CPH.TO generate free cash flow?

Cipher Pharmaceuticals Inc. (CPH.TO) generated $30.22M of free cash flow in fiscal 2025.

How much operating cash flow does CPH.TO produce?

Operating cash flow was $30.25M, before capital expenditures of $28,486.00.